"Harnessing The Power Of Nature: A Review Of Herbal Plants For Managing Anxiety"
Article Sidebar
Main Article Content
Abstract
The most prevalent mental illnesses are anxiety disorders. Disturbances in emotion, thinking, behavior, and bodily functions are some of its symptoms. It encompasses obsessive-compulsive disorder, panic disorder, agoraphobia, generalized anxiety disorder, specific phobia, social phobia, acute stress disorder, and post-traumatic stress disorder.
The current study aims to provide light on the symptoms, etiology, pathophysiology, indicators, and treatments associated with anxiety. Anxiety is frequently accompanied by symptoms that interfere with sleep, focus, social and/or professional functioning. Anxiety is linked to restlessness, tenseness, or feeling on edge.easily worn out, agitated, tense in the muscles, inability to focus or lose one's train of thought. Anxiety may have multiple etiologies, such as stress, physical health issues, genetics, and environmental influences. A disturbance in the central nervous system's regulation could be the cause of anxiety symptoms. Many people think that the development of it is caused by reduced serotonin system activity and high noradrenergic system activity. Consequently, the first-line treatment for it is a combination of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Munir, Sadaf, and Veronica Takov. "Generalized anxiety disorder." (2017).
https://www.ncbi.nlm.nih.gov/books/NBK441870
Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention?. Jama. 1989 Sep 15;262(11):1479-84.
Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, Ballenger JC, Fyer AJ. The economic burden of anxiety disorders in the 1990s. Journal of clinical psychiatry. 1999 Jul 15;60(7):427-35.
Liu L, Liu C, Wang Y, Wang P, Li Y, Li B. Herbal medicine for anxiety, depression and insomnia. Current neuropharmacology. 2015 Jul 1;13(4):481-93.
Anderson JG, Taylor AG. Use of complementary therapies for cancer symptom management: results of the 2007 National Health Interview Survey. The journal of alternative and complementary medicine. 2012 Mar 1;18(3):235-41.
Brown LF, Kroenke K, Theobald DE, Wu J, Tu W. The association of depression and anxiety with health‐related quality of life in cancer patients with depression and/or pain. Psycho‐Oncology. 2010 Jul;19(7):734-41.
Hong JS, Tian J. Prevalence of anxiety and depression and their risk factors in Chinese cancer patients. Supportive care in cancer. 2014 Feb;22:453-9.
Pinquart M, Duberstein P. Depression and cancer mortality: a meta-analysis. Psychological medicine. 2010 Nov;40(11):1797-810.
Petrović B, Vukomanović P, Popović V, Jovović Z, Nikolić M, Šarčević-Todosijević L, Jović S. Herbal remedies in the treatment of anxiety disorders. An introduction to medicinal herbs. 2021:205-36.
Beesdo-Baum K, Knappe S. Developmental epidemiology of anxiety disorders. Child and Adolescent Psychiatric Clinics. 2012 Jul 1;21(3):457-78.
Petrović B, Vukomanović P, Popović V, Šarčević-Todosijević L, Burić M, Nikolić M, Đorđević S. Significance and efficacy of triterpene saponin herbal drugs with expectorant action in cough therapy. Agriculture and Forestry. 2022;68(3):221-39.
Gupta V, Bansal P, Kumar S, Sannd R, Rao MM. Therapeutic efficacy of Phytochemicals as anti-anxiety-a review. J Pharm Res. 2010 Jan;3(1):174-9.
JD B. Biochemical hypotheses of mood and anxiety disorders. Basic neurochemistry: molecular, cellular and medical aspects (CD-ROM). 1998.
Lépine JP. The epidemiology of anxiety disorders: prevalence and societal costs. Journal of Clinical Psychiatry. 2002 Jan 1;63:4-8.
MR VM, Ranjekar PK, Ramassamy C, Deshpande M. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha. Central Nervous System Agents in Medicinal Chemistry. 2010 Sep 1;10(3):238-46.
Bhattacharya SK, Muruganandam AV. Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacology Biochemistry and Behavior. 2003 Jun 1;75(3):547-55.
Kulkarni SK, Dhir A. Withania somnifera: an Indian ginseng. Progress in neuro-psychopharmacology and biological psychiatry. 2008 Jul 1;32(5):1093-105.
Andrade C, Aswath A, Chaturvedi SK, Srinivasa M, Raguram R. A double-blind, placebo-controlled evaluation of the anxiolytic efficacy ff an ethanolic extract of withania somnifera. Indian journal of psychiatry. 2000 Jul;42(3):295.
Salve J, Pate S, Debnath K, Langade D, Langade DG. Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus. 2019 Dec 25;11(12).
Mehta AK, Binkley P, Gandhi SS, Ticku MK. Pharmacological effects of Withania somnifera root extract on GABAA receptor complex. The Indian Journal of Medical Research. 1991 Aug 1;94:312-5.
Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine. 2005 Apr 20;12(4):305-17.
Chatterjee M, Verma P, Palit G. Comparative evaluation of Bacopa monniera and Panax quniquefolium in experimental anxiety and depressive models in mice.2010.
Stough C, Lloyd J, Clarke J, Downey L, Hutchison C, Rodgers T, Nathan P. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology. 2001 Aug;156:481-4.
Kenda M, Kočevar Glavač N, Nagy M, Sollner Dolenc M. Medicinal plants used for anxiety, depression, or stress treatment: An update. Molecules. 2022 Sep 15;27(18):6021.
Bilia AR, Gallori S, Vincieri FF. Kava-kava and anxiety: growing knowledge about the efficacy and safety. Life Sciences. 2002 Apr 19;70(22):2581-97.
Raduege KM, Kleshinski JF, Ryckman JV, Tetzlaff JE. Anesthetic considerations of the herbal, kava. Journal of clinical anesthesia. 2004 Jun 1;16(4):305-11.
Singh YN, Singh NN. Therapeutic potential of kava in the treatment of anxiety disorders. CNS drugs. 2002 Nov;16:731-43.
Andrews G, Hobbs MJ, Borkovec TD, Beesdo K, Craske MG, Heimberg RG, Rapee RM, Ruscio AM, Stanley MA. Generalized worry disorder: A review of DSM‐IV generalized anxiety disorder and options for DSM‐V. Depression and anxiety. 2010 Feb;27(2):134-47.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of general psychiatry. 2005 Jun 1;62(6):593-602.
Kessler RC, DuPont RL, Berglund P, Wittchen HU. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. American journal of psychiatry. 1999 Dec 1;156(12):1915-23.
Reinhold JA, Rickels K. Pharmacological treatment for generalized anxiety disorder in adults: an update. Expert opinion on pharmacotherapy. 2015 Jul 24;16(11):1669-81.
Mitte K, Noack P, Steil R, Hautzinger M. A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder. Journal of clinical psychopharmacology. 2005 Apr 1;25(2):141-50.
Bystritsky A, Hovav S, Sherbourne C, Stein MB, Rose RD, Campbell-Sills L, Golinelli D, Sullivan G, Craske MG, Roy-Byrne PP. Use of complementary and alternative medicine in a large sample of anxiety patients. Psychosomatics. 2012 May 1;53(3):266-72.
Nakazawa T, Yasuda T, Ueda J, Ohsawa K. Antidepressant-like effects of apigenin and 2, 4, 5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test. Biological and Pharmaceutical Bulletin. 2003;26(4):474-80.
Yonkers KA, Bruce SE, Dyck IR, Keller MB. Chronicity, relapse, and illness—course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow‐up. Depression and anxiety. 2003;17(3):173-9.
Salamon I. Chamomile: a medicinal plant. The Herb, spice and medicinal plant digest. 1992.
EMA H. Community herbal monograph on Rosmarinus officinalis L., folium. EMA/HMPC/13633/2009, 15 July; 2010.
Wichtl M, Bauer R, Blaschek W. Wichtl-Teedrogen und Phytopharmaka: ein Handbuch für die Praxis: mit 703 vierfarbigen und 303 schwarz-weißen Abbildungen, 171 Formel Kästen mit 521 Formelzeichnungen. Wissenschaftliche Verlagsgesellschaft; 2016.
Kasper S, Gastpar M, Müller WE, Volz HP, Möller HJ, Schläfke S, Dienel A. Lavender oil preparation Silexan is effective in generalized anxiety disorder–a randomized, double-blind comparison to placebo and paroxetine. International Journal of Neuropsychopharmacology. 2014 Jun 1;17(6):859-69.
Kenda M, Kočevar Glavač N, Nagy M, Sollner Dolenc M. Medicinal plants used for anxiety, depression, or stress treatment: An update. Molecules. 2022 Sep 15;27(18):6021.
Krenn L. Passion Flower (Passiflora incarnata L.)--a reliable herbal sedative. Wiener Medizinische Wochenschrift (1946). 2002 Jan 1;152(15-16):404-6.
Meier B. Passiflorae, herba-pharmazeutische Qualität. Zeitschrift fur Phytotherapie. 1995;16:90-.
Miroddi M, Calapai G, Navarra M, Minciullo PL, Gangemi S. Passiflora incarnata L.: ethnopharmacology, clinical application, safety and evaluation of clinical trials. Journal of ethnopharmacology. 2013 Dec 12;150(3):791-804.
Fonseca LR, Rodrigues RD, Ramos AD, da Cruz JD, Ferreira JL, Silva JR, Amaral AC. Herbal medicinal products from Passiflora for anxiety: An unexploited potential. The Scientific World Journal. 2020 Jul 20;2020.
Dhawan K, Dhawan S, Sharma A. Passiflora: a review update. Journal of ethnopharmacology. 2004 Sep 1;94(1):1-23.
Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. European neuropsychopharmacology. 2011 Dec 1;21(12):841-60.
Wohlmuth H, Penman KG, Pearson T, Lehmann RP. Pharmacognosy and chemotypes of passionflower (Passiflora incarnata L.). Biological and Pharmaceutical bulletin. 2010 Jun 1;33(6):1015-8.
Appel K, Rose T, Fiebich B, Kammler T, Hoffmann C, Weiss G. Modulation of the γ‐aminobutyric acid (GABA) system by Passiflora incarnata L. Phytotherapy Research. 2011 Jun;25(6):838-43.
Nassiri-Asl M, Zaman Soltani F, Shariati-Rad S. Possible role of GABAA-benzodiazepine receptor in anticonvulsant effects of Pasipay in rats. Zhong xi yi jie he xue bao= Journal of Chinese Integrative Medicine. 2008 Nov 1;6(11):1170-3.
Lutomski J, Wrocinski T. Pharmacodynamic properties of P. incarnata preparations. The effect of alkaloid and flavonoid components on pharmacodynamic properties of the raw materials. Biul. Inst. Rosl. Lecz. 1960;6:176-84.
Wasowski C, Marder M. Flavonoids as GABAA receptor ligands: the whole story?. Journal of experimental pharmacology. 2012 Feb 23:9-24.
Salerno S, Da Settimo F, Taliani S, Simorini F, La Motta C, Fornaciari G, Maria Marini A. Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents. Current Topics in Medicinal Chemistry. 2012 Feb 1;12(4):286-311